C3 - complement component 3 Gene

种属: Mus musculus

同用名: ASP; Plp; HSE-MSF

基因 ID: 12266 | 基因类型: protein coding

关于 C3

功能概要

This gene encodes complement protein C3 which plays a central role in the classical, alternative and lectin activation pathways of the Complement System. The encoded preproprotein undergoes a multi-step processing to generate various functional Peptides. Mice deficient in the encoded protein fail to clear bacteria from the blood stream upon Infection, display diminished airway hyperresponsiveness and lung eosinophilia upon allergen-induced pulmonary allergy, and develop severe lung injury after deposition of IgG immune complexes. Deficiency of the homolog of the encoded protein in humans was found to be associated with increased susceptibility to infections, age-related macular degeneration, and atypical hemolytic uremic syndrome. [provided by RefSeq, Mar 2015]

C3 基因产物(1)

mRNA	Protein	Name
NM_009778.3	NP_033908.2	complement C3 preproprotein

基因本体论

分子功能
生物过程
细胞组分

分子功能 GO 注释	逻辑证据	参考文献	来源
enables protein binding	IPI IPI: 通过物理相互作用推断	11728339	MGI

生物过程 GO 注释	逻辑证据	参考文献	来源
involved in amyloid-beta clearance	IGI IGI: 通过遗传相互作用推断	20199584	MGI
involved in amyloid-beta clearance	IMP IMP: 通过突变表型推断	22438044	MGI
acts upstream of or within complement activation	IDA IDA: 通过直接分析推断	18947875	MGI
acts upstream of or within complement activation	IMP IMP: 通过突变表型推断	25284781	MGI
involved in complement receptor mediated signaling pathway	IMP IMP: 通过突变表型推断	22632727	MGI
acts upstream of or within complement-dependent cytotoxicity	IMP IMP: 通过突变表型推断	25284781	MGI
involved in complement-mediated synapse pruning	IMP IMP: 通过突变表型推断	18083105	MGI
involved in neuron remodeling	IMP IMP: 通过突变表型推断	18083105	MGI
acts upstream of or within oviduct epithelium development	IGI IGI: 通过遗传相互作用推断	31604923	MGI
involved in positive regulation of activation of membrane attack complex	IMP IMP: 通过突变表型推断	15611275	MGI
involved in positive regulation of angiogenesis	IMP IMP: 通过突变表型推断	15611275	MGI
acts upstream of or within positive regulation of phagocytosis	IMP IMP: 通过突变表型推断	11901193	MGI
involved in positive regulation of phagocytosis, engulfment	IGI IGI: 通过遗传相互作用推断	20199584	MGI
involved in positive regulation of phagocytosis, engulfment	IMP IMP: 通过突变表型推断	22438044	MGI
involved in positive regulation of receptor-mediated endocytosis	IGI IGI: 通过遗传相互作用推断	20199584	MGI
involved in positive regulation of receptor-mediated endocytosis	IMP IMP: 通过突变表型推断	22438044	MGI
acts upstream of or within positive regulation of type IIa hypersensitivity	IMP IMP: 通过突变表型推断	11901193	MGI
acts upstream of or within response to bacterium	IEP IEP: 通过表达模式推断	23012479	MGI
acts upstream of or within retina development in camera-type eye	IGI IGI: 通过遗传相互作用推断	28057640	MGI
acts upstream of or within vascular associated smooth muscle cell differentiation	IGI IGI: 通过遗传相互作用推断	28057640	MGI
involved in vertebrate eye-specific patterning	IMP IMP: 通过突变表型推断	18083105	MGI

细胞组分 GO 注释	逻辑证据	参考文献	来源
located in cell surface	IDA IDA: 通过直接分析推断	25284781	MGI
located in extracellular region	IDA IDA: 通过直接分析推断	19411110	MGI
located in extracellular space	IDA IDA: 通过直接分析推断	18292556	MGI
part of protein-containing complex	IDA IDA: 通过直接分析推断	23487775	MGI

EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断

蛋白主名

其他名称

complement C3

acylation stimulating protein	complement component 3d
complement factor 3

重组 C3 蛋白

目录号	产品名	蛋白编号	纯度
HY-P7863	Complement C3/C3a Protein, Mouse	P01027-1 (S671-R748)	≥95%
HY-P78247	Complement C3 Protein, Mouse (HEK293, His)	P01027-1 (I25-N1663)	≥95%

相关产品

Approval

抗体抑制剂 (1)

目录号	产品名	作用方式	纯度	是否罕见病
HY-P99050	Sutimlimab	Inhibitor	98.81%	否

Clinical Phase

生物活性分子 (15)

目录号	产品名	作用方式	纯度	Phase
HY-14605BS	Rasagiline-13C3 mesylate racemic	Inhibitor	/	Phase 4
HY-127105	Iptacopan	Inhibitor	99.96%	Phase 3
HY-106178	PMX-53	Antagonist	98.60%	Phase 2
HY-P1717A	AMY-101 TFA	Inhibitor	99.89%	Phase 2
HY-P1717B	AMY-101 acetate	Inhibitor	99.93%	Phase 2
HY-19903	ASP-9521	Inhibitor	≥98.0%	Phase 2
HY-P3204	POT-4	Inhibitor	99.64%	Phase 2
HY-124573	OBI-3424		99.23%	Phase 2
HY-P2141	TRV-120027	Agonist	99.46%	Phase 2
HY-P2141A	TRV-120027 TFA	Agonist	99.69%	Phase 2
HY-N9481	Lipoteichoic acid	Activator	/	Phase 2
HY-P1717	AMY-101	Inhibitor	/	Phase 2
HY-108325A	Brequinar sodium		/	Phase 2
HY-P3204A	POT-4 TFA	Inhibitor	/	Phase 2
HY-10819	AG2034	Inhibitor	/	Phase 1

抗体抑制剂 (2)

目录号	产品名	作用方式	纯度	Phase
HY-P990091	Riliprubart	Inhibitor	99.90%	Phase 3
HY-P990025	Empasiprubart		97.93%	Phase 2

Pre-clinical Phase

生物活性分子 (534)

Cat. No.	产品名	作用方式	纯度	是否罕见病
HY-101502A	SB290157 trifluoroacetate	Antagonist	99.87%	否
HY-12481	SAR405	Inhibitor	99.49%	否
HY-N0376	Liquiritin		99.68%	否
HY-112842	MBQ-167	Inhibitor	99.86%	否
HY-138161	JR14a	Antagonist	99.59%	否
HY-P1036	Compstatin	Inhibitor	99.76%	否
HY-132295	Azenosertib	Inhibitor	99.96%	否
HY-Y0479AS	L-Lactic acid-13C3 sodium		≥98.0%	否
HY-15976	P7C3		99.85%	否
HY-103007	TC-G-1008	Agonist	99.61%	否
HY-15978	P7C3-A20		98.97%	否
HY-125877	PROTAC Mcl1 degrader-1	Inhibitor	98.13%	否
HY-P2848	Cholesterol oxidase, Microorganism		≥90.0%	否
HY-128358	MR-L2	Activator	99.23%	否
HY-Y0479S	L-Lactic acid-13C3		99.10%	否
HY-108568	15-Deoxy-Δ-12,14-prostaglandin J2	Agonist	≥99.0%	否
HY-112633	SMN-C3	Modulator	99.89%	是
HY-P1345A	TLQP-21 TFA	Agonist	99.90%	否
HY-128132	C3a receptor agonist 1	Agonist	98.04%	否
HY-W015913S	Sodium 2-oxopropanoate-13C3	Inhibitor	99.7%	否
HY-138557	AKR1C3-IN-4	Inhibitor	99.77%	否
HY-134978	(Rac)-SHIN2	Inhibitor	99.40%	否
HY-N0650S	L-Serine-13C3		98.20%	否
HY-N6978	Ascr#5		≥98.0%	否
HY-147090	Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH	Degrader	98.24%	否
HY-Y0337S	L-Cysteine-13C3,15N		99.9%	否
HY-161022A	FL118-C3-O-C-amide-C-NH2 formate		95.82%	否
HY-150644	S07-2010	Inhibitor	99.79%	否
HY-107379	AKR1C3-IN-1	Inhibitor	98.23%	否
HY-126521	N3-C3-NHS ester		≥98.0%	否
HY-133479	Tetrazine-Ph-NHCO-C3-NHS ester		98.28%	否
HY-B1337S4	Choline Chloride-13C3		99.69%	否
HY-P3252A	Pegcetacoplan acetate	Inhibitor	98.72%	否
HY-130142A	Biotinyl-NH-PEG3-C3-amido-C3-COOH		99.91%	否
HY-140902A	Biotin-PEG3-C3-NH2		≥97.0%	否
HY-N10361	Drupanin		98.05%	否
HY-103612	Thalidomide-O-amido-C3-COOH	Inducer	98.43%	否
HY-113248S1	3-Nitro-L-tyrosine-13C6		≥95.0%	否
HY-133689AS	3-Nitrophenylhydrazine-13C6 hydrochloride		98.26%	否
HY-162266	C3TD879	Inhibitor	99.42%	否
HY-N1981S	Triolein-13C3	Inhibitor	98.00%	否
HY-131011	Furanone C-30	Inhibitor	≥98.0%	否
HY-145127	ETZ		97.06%	否
HY-155035	S07-1066	Inhibitor	99.48%	否
HY-D1342	Coumberol		99.99%	否
HY-W422359A	2-Aminopurine-O-Ph-NHCO-C3-COOH hydrochloride		95.27%	否
HY-131185	Pomalidomide-amido-C3-COOH		99.51%	否
HY-100683	A12B4C3	Inhibitor	98.0%	否
HY-113128S	sn-Glycerol 3-phosphate-13C3 disodium		98.7%	否
HY-133618	Pomalidomide-C3-adavosertib	Degrader	99.84%	否
HY-135306	Cl-C6-PEG4-C3-COOH		99.65%	否
HY-152189	S19-1035		99.77%	否
HY-N0650S5	L-Serine-13C3,15N		≥99.0%	否
HY-W004701	Br-C3-methyl ester		98.61%	否
HY-W006057AS16	Sodium 3-methyl-2-oxobutanoate-13C5		99.00%	否
HY-Y0337S4	L-Cysteine-13C3		99.90%	否
HY-103608	(S,R,S)-AHPC-(C3-PEG)2-C6-Cl		99.89%	否
HY-108568S	15-Deoxy-Δ-12,14-prostaglandin J2-d4	Agonist	98.10%	否
HY-117992	BR103		99.75%	否
HY-130711B	(S,R,S)-AHPC-C3-NH2 hydrochloride		96.38%	否
HY-B1659S5	Glycerol-13C3		99.10%	否
HY-N0322S4	Cholesterol-13C3	Agonist	98.80%	否
HY-N0680S3	Thiamine-13C3 hydrochloride		99.90%	否
HY-P1505A	C3a (70-77) (TFA)		95.02%	否
HY-12481A	SAR405 R enantiomer		99.94%	否
HY-145225	DLin-K-C3-DMA	Chemical	≥98.0%	否
HY-128856	P7C3-OMe		98.26%	否
HY-140928	Biotin-PEG4-amino-t-Bu-DADPS-C3-alykne		≥95.0%	否
HY-148142	Pomalidomide-C3-NHS ester		98.70%	否
HY-152188	AKR1C3-IN-9	Inhibitor	99.37%	否
HY-161022S1	FL118-C3-O-C-amide-C-NH2-d5 formate		/	否
HY-B1342S3	Retinol-13C3		95.71%	否
HY-N0136S1	(±)-Taxifolin-13C3	Inhibitor	99.63%	否
HY-R00006	hsa-let-7c-3p mimic		93.63%	否
HY-R00717	hsa-miR-34c-3p mimic		94.18%	否
HY-R01568	hsa-miR-518c-3p mimic		92.33%	否
HY-R01678	hsa-miR-548c-3p mimic		92.16%	否
HY-RI00407	hsa-miR-200c-3p inhibitor		94.62%	否
HY-W004640	N-Boc-C1-PEG3-C3-NH2		≥98.0%	否
HY-115560A	Thalidomide-O-amido-C3-NH2 TFA	Inducer	99.58%	否
HY-131646	Thalidomide-O-amido-C3-PEG3-C1-NH2	Inducer	99.08%	否
HY-109154	Obafistat	Inhibitor	99.92%	否
HY-P1036A	Compstatin TFA	Inhibitor	99.02%	否
HY-100196S1	Pyrroloquinoline quinone-13C3 sodium		99.29%	否
HY-113008AS	cis-Urocanic acid-13C3	Agonist	99.46%	否
HY-120903	DBCO-C3-Acid		≥95.0%	否
HY-131455A	Biotin-C1-PEG3-C3-amido-C5-Gly-Arg-Gly-N3 TFA		≥98.0%	否
HY-131888	Pomalidomide-C3-NH2 hydrochloride		95.38%	否
HY-138847A	Thalidomide-4-O-C3-NH2 hydrochloride	Inducer	/	否
HY-139683	Antiviral agent 5	Chemical	98.93%	否
HY-144432S	Vitamin B5-13C3,15N hemicalcium hemihydrate		99.7%	否
HY-150156	Anti-inflammatory agent 32		99.52%	否
HY-15129S	O-Phospho-L-serine-13C3,15N	Modulator	99.19%	否
HY-158118	Lys(CO-C3-p-I-Ph)-OMe		97.19%	否
HY-158122	Lys(CO-C3-p-I-Ph)-O-tBu		98.14%	否
HY-160897	Methoxy-PEG-C3-amide-C2-Mal		99.69%	否
HY-161022	FL118-C3-O-C-amide-C-NH2		/	否
HY-161022S	FL118-C3-O-C-amide-C-NH2-d5		/	否
HY-40354S	Tofacitinib-13C3		/	否
HY-B1773AS3	Propanoic-13C3 sodium		/	否
HY-D1056C1	Lipopolysaccharides, from S. enterica serotype enteritidis	Activator	/	否
HY-N0437S2	Progesterone-13C3	Agonist	99.60%	否
HY-N0898S	Catechin-13C3		98.06%	否
HY-N2362S1	DL-Alanine-13C-3		≥98.0%	否
HY-N4134	Ciwujianoside C3	Inhibitor	≥98.0%	否
HY-N6685S1	3-Acetyldeoxynivalenol-13C17		≥99.0%	否
HY-P1505	C3a (70-77)		/	否
HY-R00840	hsa-miR-376c-3p mimic		93.13%	否
HY-RI00840	hsa-miR-376c-3p inhibitor		99.33%	否
HY-W010407S	Cyanuric acid-13C3		≥98.0%	否
HY-W010421S	Ammelide-13C3		99.85%	否
HY-B0356AS1	Ciprofloxacin-13C3,15N monohydrochloride		99.9%	否
HY-W392808	Spacer phosphoramidite C3		≥98.0%	否
HY-115560	Thalidomide-O-amido-C3-NH2	Inducer	/	否
HY-130711A	(S,R,S)-AHPC-C3-NH2 TFA		/	否
HY-131876	Thalidomide-O-C3-acid	Inducer	/	否
HY-135900	Aniline-MPB-amino-C3-PBD	Inhibitor	/	否
HY-130711	(S,R,S)-AHPC-C3-NH2		/	否
HY-131186	Pomalidomide-amido-C3-piperazine-N-Boc		/	否
HY-100582S2	Ribitol-3-13C		/	否
HY-111297	BMVC4		/	否
HY-112251S	D-Lin-MC3-DMA-13C3		/	否
HY-113008S1	Urocanic acid-13C3		/	否
HY-113357S	m-Coumaric acid-13C3		/	否
HY-114773	N-Undecanoyl-L-homoserine lactone		/	否
HY-115902	FGFR4-IN-7		/	否
HY-116021S	Buquinolate-13C3	Inhibitor	/	否
HY-116025	APN-C3-PEG4-alkyne		/	否
HY-116084S1	Trimethylamine-N-oxide-13C3	Activator	/	否
HY-117074	BMS-247243		/	否
HY-121412	Lankacidin C	Inhibitor	/	否
HY-121635	FOX-7		/	否
HY-12210	(S)-BI-1001	Inhibitor	/	否
HY-12542S	Dantrolene-13C3	Inhibitor	≥99.0%	否
HY-126287	JND4135		/	否
HY-128748S4	DL-Glyceraldehyde-13C3		/	否
HY-128753S4	D-Lyxose-13C-3		/	否
HY-129974S	3,3'-Diiodo-L-thyronine-13C6		/	否
HY-130142	Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA)		/	否
HY-130585S	Estradiol undecylate-13C3		/	否
HY-130711C	(S,R,S)-AHPC-C3-NH2 dihydrochloride		/	否
HY-131184	N-Boc-piperazine-C3-COOH		/	否
HY-131190	N-Boc-SBP-0636457-O-C3-COOH		/	否
HY-131800	3'-Deoxy-3'-amino-ATP		/	否
HY-131888A	Pomalidomide-C3-NH2		/	否
HY-133403A	Biotin-C1-PEG3-C3-amine TFA		/	否
HY-133584	Bis-SS-C3-NHS ester		/	否
HY-133585	Bis-SS-C3-sulfo-NHS ester		/	否
HY-133702	Aniline-piperazine-C3-NH-Boc		/	否
HY-134679	N-Boc-C1-PEG5-C3-NH2		/	否
HY-134692	Azido-C1-PEG3-C3-NH2		/	否
HY-134693	Azido-C1-PEG4-C3-NH2		/	否
HY-134749	Propargyl-PEG2-urea-C3-triethoxysilane		/	否
HY-135901	Py-MPB-amino-C3-PBD	Inhibitor	/	否
HY-13632S1	Exemestane-13C3	Inhibitor	/	否
HY-136457S	2-NP-AHD-13C3		/	否
HY-13653S	(+/-)-Epigallocatechin Gallate-13C3		/	否
HY-138847	Thalidomide-O-C3-NH2	Inducer	/	否
HY-138850	Thalidomide-NH-amido-C3-NH2	Inducer	/	否
HY-138850A	Thalidomide-NH-amido-C3-NH2 hydrochloride	Inducer	/	否
HY-139145S	Etbicyphat-13C3		/	否
HY-139427S	3-Methylglutaconic acid-13C3		/	否
HY-139545	Thalidomide-4-C3-NH2 hydrochloride	Inducer	/	否
HY-139721	Tenofovir-C3-O-C15-CF3 ammonium	Inhibitor	/	否
HY-139722	Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium	Inhibitor	/	否
HY-140019	Azido-PEG3-amide-C3-triethoxysilane		/	否
HY-140288	DBCO-C3-PEG4-amine		/	否
HY-140295	DBCO-C3-PEG4-NH-Boc		/	否
HY-140347	APN-C3-NH-Boc		/	否
HY-140478	Boc-NH-PEG4-C3-acid		/	否
HY-140808	Azido-PEG3-C3-OH		/	否
HY-140841	APN-C3-PEG4-azide		98.56%	否
HY-140902	rel-Biotin-PEG3-C3-NH2		/	否
HY-140927	Azido-C3-UV-biotin		/	否
HY-141065	N-(azide-PEG3)-N'-(Amine-C3-Amide-PEG4)-Cy5		/	否
HY-141407	m-PEG3-amido-C3-triethoxysilane		/	否
HY-141597	Acid-C3-SSPy		/	否
HY-141651	(S,R,S)-AHPC-C3-COOH		/	否
HY-141857S	5-(4-Hydroxyphenyl)-5-phenyl-d5-hydantoin-2,4,5-13C3		/	否
HY-141893	3-Cyanovinylcarbazole phosphoramidite	Inhibitor	/	否
HY-141901S2	Dehydroepiandrosterone-13C3		/	否
HY-141907S	17β-Estradiol-13C3		/	否
HY-142140S	3-epi-25-Hydroxy Vitamin D3-d6		/	否
HY-143342	LEB-03-144		/	否
HY-143400	HSP70-IN-3	Inhibitor	/	否
HY-143439	LX-039	Antagonist	/	否
HY-144749	AKR1C3-IN-5		/	否
HY-145253	Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH	Inhibitor	/	否
HY-145254	Tri(TLR4-IN-C34-PEG2-amide-PEG1)-amide-C3-COOH	Inhibitor	/	否
HY-145255	Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH	Inhibitor	/	否
HY-14605S	Rasagiline-13C3 mesylate		/	否
HY-146573	AKR1C3-IN-6	Inhibitor	/	否
HY-146574	AKR1C3-IN-7	Inhibitor	/	否
HY-146575	AKR1C3-IN-8	Inhibitor	/	否
HY-148460	Mal-VC-PAB-(N-Me-amide-C3)-ADU-S100 triethylamine		/	否
HY-148471A	C3-Amide-C4-NH2		/	否
HY-149749	Methylthiomcresol-C3-COOH		/	否
HY-150624	SARS-CoV-2 nsp13-IN-3	Inhibitor	/	否
HY-150646	S07-2009		/	否
HY-150648	S07-2008	Inhibitor	/	否
HY-150649	S07-2005 (racemic)		/	否
HY-150650	S07-2001		/	否
HY-15097S	Myricetin-13C3	Inducer	/	否
HY-153456	Hedgehog IN-2	Inhibitor	/	否
HY-15398S1	Vitamin D3-13C3	Activator	/	否
HY-155259	Pomalidomide-5-C3-NH2 hydrochloride		96.02%	否
HY-155502	AKR1C3-IN-10	Inhibitor	/	否
HY-155716	G43-C3-TEG	Inhibitor	/	否
HY-156086	TRK-IN-24	Inhibitor	/	否
HY-157510	Thalidomide-O-C3-azide		/	否
HY-157810	AKR1C3-IN-11	Inhibitor	/	否
HY-158383	Pomalidomide-CO-C3-PEG4-C6-NH2		/	否
HY-158732	MAO-B-IN-33	Inhibitor	/	否
HY-159604	METTL3-IN-9	Inhibitor	/	否
HY-15977	(S)-P7C3-OMe		/	否
HY-161131	Lenalidomide 4'-alkyl-C3-azide		/	否
HY-161468	Thalidomide-N-C3-O-C4-O-C3-OH	Inducer	/	否
HY-161653	Boc-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione		/	否
HY-161708	PROTAC FLT3/CDKs degrader-1	Degrader	/	否
HY-161832	(S,R,S)-Me-AHPC-amide-C3-alkyne		/	否
HY-161839	AKR1C2/3-IN-1	Inhibitor	/	否
HY-161929	GPX4 activator 2		/	否
HY-162714	C3N-Dbn-Trp2	Inhibitor	/	否
HY-162816	PROTAC HPK1 Degrader-3		/	否
HY-163223	(S,R,S)-AHPC-CO-CH2-piperazine-C3-piperazine-Boc		/	否
HY-163267	ZNL0325		/	否
HY-163323	AKR1C3-IN-12	Inhibitor	/	否
HY-163609	PROTAC AKR1C3 degrader-1	Degrader	/	否
HY-163610	AKR1C3-IN-13	Inhibitor	/	否
HY-163678	Pomalidomide-CO-C7-NH-CO-C3-COOH		/	否
HY-163758	COOH-C3-CONH-C7-COOH		/	否
HY-163784	AKR1C3-IN-14	Inhibitor	/	否
HY-163821	HO-CONH-C3-PEG3-NH2		/	否
HY-163903	OH-C2-PEG3-NHCO-C3-COOH		/	否
HY-163904	(S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH		/	否
HY-163940	LX1	Inhibitor	/	否
HY-163962	L18I		/	否
HY-163964	Lenalidomide-C3-PEG3-N3		/	否
HY-164085	Azide-C3-NHCO-C3-NHS ester		/	否
HY-17461S	Cortisone-13C3	Agonist	/	否
HY-18085S2	Quercetin-13C3		/	否
HY-19717S	DCVC-13C3,15N		/	否
HY-23506S	1-Aminoimidazolidine-2,4-dione-13C3		/	否
HY-32351B	3-epi-Calcifediol		/	否
HY-34628S1	Tri-O-acetyl-D-glucall-13C-1		/	否
HY-34628S2	Tri-O-acetyl-D-glucal-13C-2		/	否
HY-79395S1	Dimethyl carbonate-13C3		/	否
HY-A0090S	Nitrofurantoin-13C3		/	否
HY-A0132S5	N-Acetyl-D-glucosamine-13C-3		/	否
HY-A0132S9	N-Acetyl-D-glucosamine-13C3,15N		/	否
HY-A0253S	Cefacetrile-13C3		/	否
HY-B0143S4	Niacin-15N,13C3		/	否
HY-B0150S1	Nicotinamide-15N,13C3	Inhibitor	/	否
HY-B0166S4	L-Ascorbic acid-13C-3		/	否
HY-B0228S3	Adenosine-3′-13C		/	否
HY-B0234S	Estrone-13C3	Agonist	/	否
HY-B0388S	Probucol-13C3	Inhibitor	/	否
HY-B0389S13	D-Glucose-13C-3		/	否
HY-B0389S18	D-Glucose-13C3-1		/	否
HY-B0389S9	D-Glucose-13C3-2		/	否
HY-B0412S3	Estriol-13C3	Antagonist	/	否
HY-B0430S	Pantothenic acid-13C3,15N hemicalcium		/	否
HY-B0495S	Lamotrigine-13C3,d3		/	否
HY-B0495S4	Lamotrigine-13C3		/	否
HY-B0510S3	Trimethoprim-13C3		/	否
HY-B0526S	Flumequine-13C3	Inhibitor	/	否
HY-B0891S1	17α-Hydroxyprogesterone-13C3	Agonist	/	否
HY-B1075AS	(Rac)-Fosfomycin (benzylamine)-13C3		/	否
HY-B1241A	Dihydrostreptomycin		/	否
HY-B1331S1	Cyromazine-13C3		/	否
HY-B1449S4	Uridine-13C-3		/	否
HY-B1659S	Glycerol-13C3,d8		/	否
HY-B1732S1	DL-3-Phenylalanine-13C		/	否
HY-D1516	NerveGreen C3		/	否
HY-D1558	1,3,5,7-Tetramethyl-2,6-diiodo-C3-SE-BODIPYs		/	否
HY-D1581	BODIPY 505/515-8-C3-COOH		/	否
HY-D2200	Cy5.5(Me)-C3-DBCO		/	否
HY-I0400S3	N-Acetylneuraminic acid-13C-3		/	否
HY-N0001S	(±)-Epicatechin-13C3		/	否
HY-N0055S	Chlorogenic acid-13C3		/	否
HY-N0059S3	D-Arabinose-13C-3		/	否
HY-N0060S1	Ferulic acid-13C3	Inhibitor	/	否
HY-N0086S3	N6-Methyladenosine-13C3	Inhibitor	/	否
HY-N0172S	Caffeic acid-13C3	Inhibitor	/	否
HY-N0210S2	D-Galactose-13C-3		/	否
HY-N0229S10	L-Alanine-13C3,15N		≥98.0%	否
HY-N0229S5	L-Alanine-13C3,15N,d4		/	否
HY-N0229S8	L-Alanine-13C3		/	否
HY-N0230S	β-Alanine-13C3,15N		/	否
HY-N0351S	p-Coumaric acid-13C3		/	否
HY-N0356S	(+/-)-Catechin Gallate-13C3	Inhibitor	/	否
HY-N0379S8	D-Mannose-13C-3		/	否
HY-N0382S	Galangin-13C3		/	否
HY-N0464S	Quinic acid-13C3		/	否
HY-N0521AS	(+)-Gallocatechin-13C3		/	否
HY-N0537S5	Xylose-3-13C		/	否
HY-N0610AS2	Cinnamic acid-13C3		99.91%	否
HY-N0650S3	L-Serine-13C3,15N,d3		/	否
HY-N0683S1	α-Vitamin E-13C3	Inhibitor	/	否
HY-N0771S6	L-Cysteine-13C3,15N,d3		/	否
HY-N10263	Palmarumycin C3		/	否
HY-N10519	Cellooctaose		/	否
HY-N10998	Chamaejasmenin A		/	否
HY-N11646	Ganorbiformin B	Inhibitor	/	否
HY-N1428S3	Citric acid-13C3		/	否
HY-N1480S3	(-)-Fucose-13C-3		/	否
HY-N2041S4	Myristic acid-13C3		/	否
HY-N3205	Neochamaejasmin B		/	否
HY-N7091S1	Atrazine-13C3,15N3		/	否
HY-N8847S	α-Ionone-13C3		/	否
HY-N9332	Kalopanax saponin G		/	否
HY-P1142S	GLP-2(rat) (Ala-13C3,15N)		/	否
HY-P1142S1	GLP-2(rat) (Ala-13C3,15N) (TFA)		/	否
HY-P1345	TLQP-21	Agonist	/	否
HY-P1640	(Trp63,Trp64)-C3a(63-77)	Agonist	/	否
HY-P2325	Exoenzyme C3, clostridium botulinum		/	否
HY-P5071	EcAMP3		/	否
HY-R00006A	hsa-let-7c-3p agomir		/	否
HY-R00333	hsa-miR-181c-3p mimic		/	否
HY-R00333A	hsa-miR-181c-3p agomir		/	否
HY-R00407	hsa-miR-200c-3p mimic		/	否
HY-R00407A	hsa-miR-200c-3p agomir		/	否
HY-R00717A	hsa-miR-34c-3p agomir		/	否
HY-R00832	hsa-miR-374c-3p mimic		/	否
HY-R00832A	hsa-miR-374c-3p agomir		/	否
HY-R00840A	hsa-miR-376c-3p agomir		/	否
HY-R01112	hsa-miR-449c-3p mimic		/	否
HY-R01112A	hsa-miR-449c-3p agomir		/	否
HY-R01546	hsa-miR-513c-3p mimic		/	否
HY-R01546A	hsa-miR-513c-3p agomir		/	否
HY-R01568A	hsa-miR-518c-3p agomir		/	否
HY-R01590	hsa-miR-519c-3p mimic		/	否
HY-R01590A	hsa-miR-519c-3p agomir		/	否
HY-R01598	hsa-miR-520c-3p mimic		/	否
HY-R01598A	hsa-miR-520c-3p agomir		/	否
HY-R01678A	hsa-miR-548c-3p agomir		/	否
HY-R02506	hsa-miR-892c-3p mimic		/	否
HY-R02506A	hsa-miR-892c-3p agomir		/	否
HY-R02698	mmu-miR-181c-3p mimic		/	否
HY-R02698A	mmu-miR-181c-3p agomir		/	否
HY-R02795	mmu-miR-1970c-3p mimic		/	否
HY-R02795A	mmu-miR-1970c-3p agomir		/	否
HY-R02833	mmu-miR-216c-3p mimic		/	否
HY-R02833A	mmu-miR-216c-3p agomir		/	否
HY-R02840	mmu-miR-219c-3p mimic		/	否
HY-R02840A	mmu-miR-219c-3p agomir		/	否
HY-R02897	mmu-miR-302c-3p mimic		/	否
HY-R02897A	mmu-miR-302c-3p agomir		/	否
HY-R03043	mmu-miR-344c-3p mimic		/	否
HY-R03043A	mmu-miR-344c-3p agomir		/	否
HY-R03077	mmu-miR-34c-3p mimic		/	否
HY-R03077A	mmu-miR-34c-3p agomir		/	否
HY-R03104	mmu-miR-374c-3p mimic		/	否
HY-R03104A	mmu-miR-374c-3p agomir		/	否
HY-R03111	mmu-miR-376c-3p mimic		/	否
HY-R03111A	mmu-miR-376c-3p agomir		/	否
HY-R03148	mmu-miR-449c-3p mimic		/	否
HY-R03148A	mmu-miR-449c-3p agomir		/	否
HY-R03198	mmu-miR-467c-3p mimic		/	否
HY-R03198A	mmu-miR-467c-3p agomir		/	否
HY-R03460	mmu-miR-669c-3p mimic		/	否
HY-R03460A	mmu-miR-669c-3p agomir		/	否
HY-R04277	rno-miR-196c-3p mimic		/	否
HY-R04277A	rno-miR-196c-3p agomir		/	否
HY-R04284	rno-miR-200c-3p mimic		/	否
HY-R04284A	rno-miR-200c-3p agomir		/	否
HY-R04468	rno-miR-449c-3p mimic		/	否
HY-R04468A	rno-miR-449c-3p agomir		/	否
HY-R04484	rno-miR-466c-3p mimic		/	否
HY-R04484A	rno-miR-466c-3p agomir		/	否
HY-RI00006	hsa-let-7c-3p inhibitor		/	否
HY-RI00006A	hsa-let-7c-3p antagomir		/	否
HY-RI00333	hsa-miR-181c-3p inhibitor		/	否
HY-RI00333A	hsa-miR-181c-3p antagomir		/	否
HY-RI00407A	hsa-miR-200c-3p antagomir		/	否
HY-RI00717	hsa-miR-34c-3p inhibitor		/	否
HY-RI00717A	hsa-miR-34c-3p antagomir		/	否
HY-RI00832	hsa-miR-374c-3p inhibitor		/	否
HY-RI00832A	hsa-miR-374c-3p antagomir		/	否
HY-RI00840A	hsa-miR-376c-3p antagomir		/	否
HY-RI01112	hsa-miR-449c-3p inhibitor		/	否
HY-RI01112A	hsa-miR-449c-3p antagomir		/	否
HY-RI01546	hsa-miR-513c-3p inhibitor		/	否
HY-RI01546A	hsa-miR-513c-3p antagomir		/	否
HY-RI01568	hsa-miR-518c-3p inhibitor		/	否
HY-RI01568A	hsa-miR-518c-3p antagomir		/	否
HY-RI01590	hsa-miR-519c-3p inhibitor		/	否
HY-RI01590A	hsa-miR-519c-3p antagomir		/	否
HY-RI01598	hsa-miR-520c-3p inhibitor		/	否
HY-RI01598A	hsa-miR-520c-3p antagomir		/	否
HY-RI01678	hsa-miR-548c-3p inhibitor		/	否
HY-RI01678A	hsa-miR-548c-3p antagomir		/	否
HY-RI02506	hsa-miR-892c-3p inhibitor		/	否
HY-RI02506A	hsa-miR-892c-3p antagomir		/	否
HY-RI02698	mmu-miR-181c-3p inhibitor		/	否
HY-RI02698A	mmu-miR-181c-3p antagomir		/	否
HY-RI02795	mmu-miR-1970c-3p inhibitor		/	否
HY-RI02795A	mmu-miR-1970c-3p antagomir		/	否
HY-RI02833	mmu-miR-216c-3p inhibitor		/	否
HY-RI02833A	mmu-miR-216c-3p antagomir		/	否
HY-RI02840	mmu-miR-219c-3p inhibitor		/	否
HY-RI02840A	mmu-miR-219c-3p antagomir		/	否
HY-RI02897	mmu-miR-302c-3p inhibitor		/	否
HY-RI02897A	mmu-miR-302c-3p antagomir		/	否
HY-RI03043	mmu-miR-344c-3p inhibitor		/	否
HY-RI03043A	mmu-miR-344c-3p antagomir		/	否
HY-RI03077	mmu-miR-34c-3p inhibitor		/	否
HY-RI03077A	mmu-miR-34c-3p antagomir		/	否
HY-RI03104	mmu-miR-374c-3p inhibitor		/	否
HY-RI03104A	mmu-miR-374c-3p antagomir		/	否
HY-RI03111	mmu-miR-376c-3p inhibitor		/	否
HY-RI03111A	mmu-miR-376c-3p antagomir		/	否
HY-RI03148	mmu-miR-449c-3p inhibitor		/	否
HY-RI03148A	mmu-miR-449c-3p antagomir		/	否
HY-RI03198	mmu-miR-467c-3p inhibitor		/	否
HY-RI03198A	mmu-miR-467c-3p antagomir		/	否
HY-RI03460	mmu-miR-669c-3p inhibitor		/	否
HY-RI03460A	mmu-miR-669c-3p antagomir		/	否
HY-RI04277	rno-miR-196c-3p inhibitor		/	否
HY-RI04277A	rno-miR-196c-3p antagomir		/	否
HY-RI04284	rno-miR-200c-3p inhibitor		/	否
HY-RI04284A	rno-miR-200c-3p antagomir		/	否
HY-RI04468	rno-miR-449c-3p inhibitor		/	否
HY-RI04468A	rno-miR-449c-3p antagomir		/	否
HY-RI04484	rno-miR-466c-3p inhibitor		/	否
HY-RI04484A	rno-miR-466c-3p antagomir		/	否
HY-RS00536	AKR1C3 Human Pre-designed siRNA Set A	Pre-designed Sets	/	否
HY-RS01743	C3 Human Pre-designed siRNA Set A	Pre-designed Sets	/	否
HY-RS01744	C3AR1 Human Pre-designed siRNA Set A	Pre-designed Sets	/	否
HY-RS05969	H3C3 Human Pre-designed siRNA Set A	Pre-designed Sets	/	否
HY-RS05976	H4C3 Human Pre-designed siRNA Set A	Pre-designed Sets	/	否
HY-RS10520	PIK3C3 Human Pre-designed siRNA Set A	Pre-designed Sets	/	否
HY-RS10521	Pik3c3 Mouse Pre-designed siRNA Set A	Pre-designed Sets	/	否
HY-RS10522	Pik3c3 Rat Pre-designed siRNA Set A	Pre-designed Sets	/	否
HY-W007376S	Indole-3-carboxaldehyde-13C		/	否
HY-W007798S	Fmoc-Cys(Trt)-OH-1,2,3-13C3,15N		/	否
HY-W007928S	1-O-Acetyl 2,3,5-tri-O-benzoyl-beta-D-ribofuranoside-13C		/	否
HY-W007941S	Fmoc-Ser(tBu)-OH-13C3,15N		/	否
HY-W009204S4	Fmoc-Ala-OH-13C3,15N		/	否
HY-W009204S5	Fmoc-Ala-OH-13C3	Modulator	/	否
HY-W010407S2	Cyanuric acid-13C3,15N3		/	否
HY-W010575S	(2R)-3-Amino-2-fluoropropanoic acid-13C3		/	否
HY-W011683S2	2'-Deoxyadenosine monohydrate-3′-13C		/	否
HY-W013061S1	Propane-1,2,3-triyl tripalmitate-13C3		/	否
HY-W013061S4	Propane-1,2,3-triyl tripalmitate-13C3-1		/	否
HY-W015084S	β-Ionone-13C3	Inducer	/	否
HY-W015824S2	DL-Aspartic acid-3-13C		/	否
HY-W017529S	6-Chloro-1,3,5-triazine-2,4-diamine-13C3		/	否
HY-W018386S	3-Bromo-L-tyrosine-13C6		/	否
HY-W018386S1	3-Bromo-L-tyrosine-13C9		/	否
HY-W018772S4	D-Ribose-13C-3		/	否
HY-W020044S	DL-alpha-Tocopherol-13C3	Inhibitor	/	否
HY-W040047S	Pregnanediol 3-glucuronide-13C5		/	否
HY-W040240S1	(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-1		/	否
HY-W040240S2	(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-2		/	否
HY-W041171S	3-Chloro-L-tyrosine-13C6		/	否
HY-W091039S	N-Acetyl-α-neuraminic acid-13C3		/	否
HY-W096151	Chloroacetamido-C-PEG3-C3-NHBoc		/	否
HY-W099927	[C3MPr]NTf2		/	否
HY-W127393	N-Nonanoyl-L-homoserine lactone		/	否
HY-W127487	N-Octadecanoyl-L-homoserine lactone		/	否
HY-W269693S	5-(4-Hydroxyphenyl)-5-phenylimidazolidine-2,4-dione-d5,13C3		/	否
HY-W324220	11β-HSD1-IN-10		/	否
HY-W357090S	L-Idose-13C-3		/	否
HY-W584535	VH032-C3-Boc		/	否
HY-W585905	Trimethylammonium chloride-13C3		/	否
HY-W653989	Desonide-13C3		/	否
HY-W753983	Pyruvic acid-13C3		/	否
HY-Y0418S3	Dulcite-13C-3		/	否
HY-Y0504S	Trimethylammonium chloride-13c3,d9		/	否
HY-Y0721S	3-Bromofluorobenzene-13C6		/	否
HY-Y0921S3	(±)-1,2-Propanediol-13C3		/	否
HY-Y1117S1	Melamine-13C3		/	否
HY-Y1117S2	Melamine-15N3,13C3		/	否
HY-Y1662	D-Aminoacylase		/	否
HY-10002S	Calcitriol-13C3	Inhibitor	≥97.0%	否
HY-100840	(S)-4C3HPG		/	否
HY-100840A	(RS)-4C3HPG	Antagonist	/	否
HY-105414	Esterbut-3		/	否
HY-105969	Dichloromethotrexate		/	否
HY-113294S	3-Hydroxykynurenine-13C3,15N		98.74%	否
HY-116170	SN34037		/	否
HY-118329	S 135		/	否
HY-118645S1	1'-Hydroxymidazolam-13C3		/	否
HY-120157	Vif-ElonginC interaction inhibitor 1	Inhibitor	/	否
HY-121656	AKR1C2/3-IN-2		/	否
HY-122585	proMMP-9 inhibitor-3c	Inhibitor	/	否
HY-137225	HTS07944		/	否
HY-139227	Thalidomide 4'-oxyacetamide-C1-PEG3-C3-amine hydrochloride	Inducer	/	否
HY-144344S	Benzyl(2R)-3-N,N-dibenzylamino-2-fluoropropanoate-13C3		/	否
HY-149560	Thalidomide-5-O-C3-NH2 hydrochloride		99.08%	否
HY-150532S	(Rac)-Vitamin B5,Calcium Salt Hydrate-13C3 15N		/	否
HY-151997S	1,2-Dioleoyl-3-lauroyl-rac-glycerol-13C3		/	否
HY-153539	AP-C3	Inhibitor	/	否
HY-153540	AP-C4	Inhibitor	/	否
HY-154746S	3-HPMA Potassium Salt-3-13C3,15N		/	否
HY-154814S	Monohydroxy-3-butenyl-mercapturic acid-13C3,15N sodium		/	否
HY-156326S	(3E,5E)-Octadien-2-one-13C2		/	否
HY-156326S1	(3E,5Z)-Octadien-2-one-13C2		/	否
HY-158861	C3-K2-E14		/	否
HY-158994S	MEGDSRGG-(Ala-13C3,15N)-GGEA-(Leu-13C6,15N)-DPESAASSLSGAS TFA		/	否
HY-159145	Lenalidomide-acetylene-C3-MsO		/	否
HY-161652	Thalidomide-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione		/	否
HY-161656	PIP-C-3-Azaspiro[5.5]undecane-boc		/	否
HY-163032	FABP4-IN-3	Inhibitor	/	否
HY-163647	Lenalidomide-COCH-PEG2-azido		/	否
HY-168192	Thalidomide-NH-C4-amide-C3-Br		/	否
HY-B0111RS	Drospirenone-13C3		/	否
HY-B0710S	Betaine-13C3		/	否
HY-B1804S	Tricaprilin-13C3		/	否
HY-N0092S4	Inosine-13C3		/	否
HY-N0368S1	Linalool-13C3		/	否
HY-N0803S1	Myrcene-13C3	Inhibitor	/	否
HY-N1071	Wilforol C		/	否
HY-N12816	Glaucogenin C 3-O-α-L-cymaropyranosyl-(1→4)–β-D-digitoxopyranosyl-(1→4)-β-D-canaropyranoside		/	否
HY-N1849	3'-Methoxyrocaglamide		/	否
HY-N2355	Solasurine		/	否
HY-N7092S22	D-Fructose-13C3		/	否
HY-N7092S23	D-Fructose-13C3-1		/	否
HY-N9522	β-D-glucopyranosyl-[α-L-rhamnopyranosyl-(1→3)-βD-glucuronopyranosyl-(1→3)]-3β-hydroxyolean-12-ene28-oate		99.95%	否
HY-W012578S1	2-Isopropyl-3-methoxypyrazine-13C3		/	否
HY-W012932S	2,4-Dimethylthiazole-13C3		/	否
HY-W046063	O-Phthalimide-C3-acid		/	否
HY-W145482S1	3-O-Methyl-D-glucopyranose-13C6		/	否
HY-W156840S	OTNE-13C3		/	否
HY-W585956	Triclocarban-13C6		/	否
HY-W654120	Creatine-13C3		/	否
HY-W654362	(R)-2-Thioxothiazolidine-4-carboxylic acid-13C3		/	否
HY-W751098	Aldosterone-13C3		/	否
HY-W751099	Corticosterone-13C3		/	否
HY-W769714	Favipiravir-13C3	Inhibitor	/	否
HY-W770183	Uric acid-13C3		/	否
HY-W778140	Diethyl phosphate-13C4 sodium	Inhibitor	/	否
HY-111843	Ch55-O-C3-NH2		/	否